These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32831069)

  • 61. Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains.
    Cencig S; Coltel N; Truyens C; Carlier Y
    Int J Antimicrob Agents; 2012 Dec; 40(6):527-32. PubMed ID: 23063742
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Trypanosoma cruzi: alteration in the lymphoid compartments following interruption of infection by early acute benznidazole therapy in mice.
    Olivieri BP; de Souza AP; Cotta-de-Almeida V; de Castro SL; Araújo-Jorge T
    Exp Parasitol; 2006 Nov; 114(3):228-34. PubMed ID: 16620811
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.
    Murta SM; Romanha AJ
    Parasitology; 1998 Feb; 116 ( Pt 2)():165-71. PubMed ID: 9509026
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mitochondrial and satellite real time-PCR for detecting T. cruzi DTU II strain in blood and organs of experimentally infected mice presenting different levels of parasite load.
    Ferreira Filho JCR; Braz LMA; Andrino MLA; Yamamoto L; Kanunfre KA; Okay TS
    Exp Parasitol; 2019 May; 200():13-15. PubMed ID: 30904696
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
    Fernández MC; González Cappa SM; Solana ME
    Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Silver and copper-benznidazole derivatives as potential antiparasitic metallodrugs: Synthesis, characterization, and biological evaluation.
    de Souza CC; de Azevedo-França JA; Barrias E; Cavalcante SCF; Vieira EG; Ferreira AMDC; de Souza W; Navarro M
    J Inorg Biochem; 2023 Feb; 239():112047. PubMed ID: 36428157
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains.
    Veloso VM; Carneiro CM; Toledo MJ; Lana M; Chiari E; Tafuri WL; Bahia MT
    Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):1005-11. PubMed ID: 11685270
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.
    Solana ME; Alba Soto CD; Fernández MC; Poncini CV; Postan M; González Cappa SM
    Parasitology; 2009 May; 136(6):627-39. PubMed ID: 19366478
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An update on benznidazole for the treatment of patients with Chagas disease.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CD8low T cells expanded following acute Trypanosoma cruzi infection and benznidazole treatment are a relevant subset of IFN-γ producers.
    Marins-Dos-Santos A; Olivieri BP; Ferreira-Reis R; de Meis J; Silva AA; de Araújo-Jorge TC; Lannes-Vieira J; Cotta-de-Almeida V
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008969. PubMed ID: 33347472
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Benznidazole therapy for Chagas disease in asymptomatic Trypanosoma cruzi -seropositive former blood donors: evaluation of the efficacy of different treatment regimens.
    Antunes AP; Ribeiro AL; Sabino EC; Silveira MF; Oliveira CD; Botelho AC
    Rev Soc Bras Med Trop; 2016; 49(6):713-720. PubMed ID: 28001218
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.
    Gulin JEN; Eagleson MA; López-Muñoz RA; Solana ME; Altcheh J; García-Bournissen F
    Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
    Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Experimental combination therapy using low doses of benznidazole and allopurinol in mouse models of Trypanosoma cruzi chronic infection.
    Rial MS; Scalise ML; López Alarcón M; Esteva MI; Búa J; Benatar AF; Prado NG; Riarte AR; Fichera LE
    Parasitology; 2019 Mar; 146(3):305-313. PubMed ID: 30301480
    [TBL] [Abstract][Full Text] [Related]  

  • 75. IL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Bolivia.
    Vásquez Velásquez C; Russomando G; Espínola EE; Sanchez Z; Mochizuki K; Roca Y; Revollo J; Guzman A; Quiroga B; Rios Morgan S; Vargas Ortiz R; Zambrana Ortega A; Espinoza E; Nishizawa JE; Kamel MG; Kikuchi M; Mizukami S; Na-Bangchang K; Tien Huy N; Hirayama K
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007715. PubMed ID: 31553732
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes.
    Martins HR; Figueiredo LM; Valamiel-Silva JC; Carneiro CM; Machado-Coelho GL; Vitelli-Avelar DM; Bahia MT; Martins-Filho OA; Macedo AM; Lana M
    J Antimicrob Chemother; 2008 Jun; 61(6):1319-27. PubMed ID: 18343804
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease.
    Sosa Estani S; Segura EL; Ruiz AM; Velazquez E; Porcel BM; Yampotis C
    Am J Trop Med Hyg; 1998 Oct; 59(4):526-9. PubMed ID: 9790423
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessing Parasite Load in Chagas Disease Patients by Quantitative Multiplex Real-Time PCR.
    Ramírez JC; da Cruz Moreira O
    Methods Mol Biol; 2019; 1955():215-225. PubMed ID: 30868530
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Monotherapy and combination chemotherapy for Chagas disease treatment: a systematic review of clinical efficacy and safety based on randomized controlled trials.
    Santana Nogueira S; Cardoso Santos E; Oliveira Silva R; Vilela Gonçalves R; Lima GDA; Dias Novaes R
    Parasitology; 2022 Nov; 149(13):1679-1694. PubMed ID: 35957576
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of short-course treatment for prevention of congenital transmission of Chagas disease: A retrospective cohort study.
    Moscatelli G; Moroni S; Ramírez JC; Warszatska B; Fernanda L; González N; Rabinovich A; Altcheh J
    PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011895. PubMed ID: 38252673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.